What is the clinical evidence from this study?

Study design: Letter. Population: Metastatic hematolymphoid tumors of the heart.

May 11, 2026Revista Colombiana de Cardiología (English Edition)0 citationsOpen Access

Metastatic hematolymphoid tumors to the heart and the diagnostic and therapeutic dilemma: additional methodological approaches

AAAndrés Arboleda-JaramilloUniversidad Cooperativa de Colombia JCJuan M. Correa-Ramírez JCJorge A. Castrillón-Lozano

Key Result

Methodological rigor and adherence to reporting guidelines such as STROBE and CARE are essential for improving the reliability of case series on metastatic hematolymphoid tumors of the heart.

PICO

Population

Metastatic hematolymphoid tumors of the heart

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Cite This Study

Arboleda-Jaramillo et al. (Wed,) conducted a letter in Metastatic hematolymphoid tumors of the heart. Methodological rigor and adherence to reporting guidelines such as STROBE and CARE are essential for improving the reliability of case series on metastatic hematolymphoid tumors of the heart.

synapsesocial.com/papers/6a025effc9581ed855361b4f https://doi.org/https://doi.org/10.24875/rccare.m25000203